Search Results - "van Loo, I.H.M."

A multicentre verification study of the QuantiFERON®-TB Gold Plus assay by Pieterman, E.D., Liqui Lung, F.G., Verbon, A., Bax, H.I., Ang, C.W., Berkhout, J., Blaauw, G., Brandenburg, A., van Burgel, N.D., Claessen, A., van Dijk, K., Heron, M., Hooghiemstra, M., Leussenkamp-Hummelink, R., van Lochem, E., van Loo, I.H.M., Mulder, B., Ott, A., Pontesilli, O., Reuwer, A., Rombouts, P., Saegeman, V., Scholing, M., Vainio, S., de Steenwinkel, J.E.M.

“…The aim of this verification study was to compare the QuantiFERON®-TB Gold Plus (QFT-Plus) to the QuantiFERON®-TB Gold In Tube (QFT-GIT). The new QFT-Plus test…”
Get full text

Exposure factors associated with SARS-CoV-2 seropositivity are not predictive for higher humoral immune responses: A cross-sectional cohort study in the general population by Hanssen, D.A.T., Pagen, D.M.E., Penders, J., Brinkhues, S., Dukers-Muijrers, N.H.T.M., Hoebe, C.J.P.A., Savelkoul, P.H.M., van Loo, I.H.M.

“…Higher antibody levels, in particular antibodies directed against the receptor-binding domain (RBD) of the spike protein, protect against re-infection with…”
Get full text

Antibodies against SARS-CoV-2 after natural infection in healthcare workers and clinical characteristics as putative antibody production prediction by Hanssen, D.A.T., Penders, J., Heijgele, K., de Leede, S., Mulder, M., Bank, L.E.A., Slaats, M.H.C., Savelkoul, P.H.M., van Loo, I.H.M.

“…There is a need for detailed data on early antibody responses against SARS-CoV-2 as this may contribute to the prediction of the clinical course of COVID-19…”
Get full text

P.023 Cytomegalovirus infection with a L595W and A692V mutation responsible for gancyclovir and possibly foscarnet resistance successfully treated by CMV hyperimmune globulins by Lutgens, S.P.M, van Loo, I.H.M, Lowe, S, Gerna, G, Goossens, V.J

Get full text

Controlling a human parainfluenza virus-3 outbreak in a haematology ward in a tertiary hospital: the importance of screening strategy and molecular diagnostics in relation to clinical symptoms by Iglόi, Z., van Loo, I.H.M., Demandt, A.M.P., Franssen, K., Jonges, M., van Gelder, M., Erkens-Hulshof, S., van Alphen, L.B.

“…The human parainfluenza virus 3 (HPIV-3) outbreak at the haemato-oncology ward of the Maastricht University Medical Centre in the summer of 2016. To describe…”
Get full text

Is there a higher risk of a complicated course of hepatitis A in kidney transplant patients? by Hanssen, D.A.T., Dackus, J., Posthouwer, D., Vennema, H., van Loo, I.H.M.

“…•HAV in kidney transplant patients is associated with an increased ICU stay and liver failure, suggesting a more fulminant course of disease.•In a cohort of…”
Get full text

Chlamydia trachomatis antibody detection in home-collected blood samples for use in epidemiological studies by Hoenderboom, B.M., van Ess, E.F., van den Broek, I.V.F., van Loo, I.H.M., Hoebe, C.J.P.A., Ouburg, S., Morré, S.A.

“…Capillary blood collected in serum tubes was subjected to centrifugation delay while stored at room temperature. Chlamydia trachomatis (CT) IgG concentrations…”
Get full text

Temporal relationship between HHV 6 and graft vs host disease in a patient after haplo-identical SCT and severe T-cell depletion by Brands-Nijenhuis, A V M, van Loo, I H M, Schouten, H C, van Gelder, M

Get full text